Edison Investment Research - Covata (CVT) Covata - Focused on European opportunity

Report

Edison Investment Research

Katherine Thompson

Covata - Focused on European opportunity

With the $2m in funds raised recently, Covata is planning to strengthen its sales and technical resources in Europe, invest in product development and provide general working capital. Management expects the imminent launch of data classification functionality and the Eclipse cloud-based offering should help drive conversion of the sales pipeline.

23/07/2018 2 EN

Underlying

Covata

Covata is a global data security solutions group based in Australia. Co. is engaged in the provision of data-centric security solutions that enable secure file sharing without compromising simple usability. Co.'s primary operating platform is the Covata Platform, developed as an enterprise specific solution to manage data security at an object level, providing an outward facing data-centric approach. In addition, Co.'s product offering includes: Covata Safe Share (protects and controls data independent of any cloud storage provider); and Covata SDK (integrates single data-centric security solutions into existing workflows and applications).

See profile

AU000000CVT5 Australia

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Analysts

Katherine Thompson

Other Reports on these Companies

Fundamental Research

Feasibility Study Results in December to be a Catalyst for this Junior

EUR 18.39

November 25, 2019 November 25, 2019 14 EN

Edison Investment Research

Covata - Funding the European opportunity

Covata has raised A$1.5m from a share placement and is also targeting a raise of up to A$1.8m from an ongoing entitlement offer. The company intends to use the proceeds to strengthen its sales and technical resources in Europe, for product development and for general working capital. The recently acquired dataglobal data classification technology should be available to use in Covata solutions from Q119.

June 14, 2018 June 14, 2018 2 EN

Electro Optic Systems - Growth from defence

Electro Optic Systems (EOS) is an optic technology company specialising in defence applications, primarily remote weapons systems (RWS) and maritime communications. The company is benefiting from increased defence spending, is well-positioned in the new frontier of drone warfare and brings optionality in future battlefield arenas of high-energy laser weapons (HELWs) and space. Improved H1 results, a strong balance sheet and an extensive pipeline position EOS to benefit from such dynamics.

8h / 13m 8h / 13m 1 EN

Toby Thorrington

Toby Thorrington

Smiths News - FY24 trading good, special dividend proposed

Smiths News’ FY24 trading was robust and results came in ahead of consensus. This, along with the debt refinancing announced in May, has resulted in lower average debt, which in turn has allowed the company to implement its revised capital allocation policy (communicated in May) and its diversification ambitions. Furthermore, it has lifted its total ordinary dividend from 4.15p to 5.15p/share and announced a ‘special’ dividend of a further 2.0p/share.

8h / 27m 8h / 27m 1 EN

Sean Conroy

Sean Conroy

IRLAB Therapeutics - Progress across the pipeline in Q324

IRLAB’s Q324 results highlighted progress across its clinical pipeline. Pirepemat cleared its final safety review and completed patient enrolment in the Phase IIb trial, making way for top-line readouts in Q125. IRL757 also made headway, reporting positive interim data from the first Phase I study and the initiation of a second study in older adults, triggering a US$2.5m (SEK26.6m) milestone payment from MSRD. Mesdopetam reported support from regulators in Germany and Portugal for the planned Phase III design, bolstering upcoming discussions with the EMA. This comes amid efforts by IRLAB towar...

23h / 59m 23h / 59m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Covata - Focused on European opportunity

Feasibility Study Results in December to be a Catalyst for this Junior

Covata - Funding the European opportunity

Electro Optic Systems - Growth from defence

Smiths News - FY24 trading good, special dividend proposed

IRLAB Therapeutics - Progress across the pipeline in Q324

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe